Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 14.67
-0.65 (-4.24%)
Oct 14, 2026, 3:00 PM CST
SHA:688670 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,807 | 2,492 | 1,493 | 3,506 | 3,783 | 6,660 | |
Market Cap Growth | -4.68% | 66.91% | -57.41% | -7.32% | -43.20% | - |
Enterprise Value | 1,741 | 2,390 | 1,258 | 2,951 | 3,265 | 5,854 |
Last Close Price | 15.32 | 20.23 | 12.12 | 28.46 | 30.62 | 53.18 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 91.06 | 80.76 |
Forward PE | - | 3.72 | 3.81 | 15.55 | 8.77 | 18.48 |
PS Ratio | 17.12 | 22.08 | 18.48 | 26.05 | 11.88 | 16.98 |
PB Ratio | 1.80 | 2.27 | 1.17 | 2.56 | 2.59 | 4.56 |
P/TBV Ratio | 1.86 | 2.33 | 1.20 | 2.63 | 2.67 | 4.70 |
P/FCF Ratio | - | - | - | 130.34 | - | - |
P/OCF Ratio | - | - | - | 43.34 | 98.02 | 64.08 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 16.51 | 21.17 | 15.57 | 21.93 | 10.25 | 14.92 |
EV/EBITDA Ratio | - | - | - | - | 56.22 | 57.02 |
EV/EBIT Ratio | - | - | - | - | 115.29 | 78.49 |
EV/FCF Ratio | - | - | - | 109.71 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.12 | 0.09 | 0.04 | 0.05 | 0.03 | 0.01 |
Debt / EBITDA Ratio | - | - | - | - | 0.72 | 0.10 |
Debt / FCF Ratio | - | - | - | 2.38 | - | - |
Net Debt / Equity Ratio | -0.06 | -0.09 | -0.30 | -0.40 | -0.36 | -0.47 |
Net Debt / EBITDA Ratio | 0.40 | 0.59 | 3.99 | 8.84 | -9.01 | -6.66 |
Net Debt / FCF Ratio | 0.42 | 0.47 | 2.27 | -20.21 | 4.04 | 2.42 |
Asset Turnover | 0.08 | 0.08 | 0.05 | 0.08 | 0.18 | 0.31 |
Inventory Turnover | 0.99 | 2.30 | 1.82 | 3.20 | 2.92 | 3.74 |
Quick Ratio | 1.35 | 1.38 | 2.59 | 3.03 | 3.00 | 4.68 |
Current Ratio | 1.58 | 1.47 | 2.76 | 3.18 | 3.14 | 4.83 |
Return on Equity (ROE) | -16.61% | -15.02% | -7.07% | -5.02% | 2.84% | 9.68% |
Return on Assets (ROA) | -8.47% | -8.11% | -4.99% | -3.30% | 0.99% | 3.68% |
Return on Invested Capital (ROIC) | -18.85% | -20.19% | -14.69% | -10.36% | 2.84% | 12.32% |
Return on Capital Employed (ROCE) | -16.80% | -16.30% | -9.60% | -6.50% | 1.90% | 4.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -10.06% | -7.16% | -6.27% | -2.02% | 1.10% | 1.24% |
FCF Yield | -8.38% | -8.08% | -11.38% | 0.77% | -3.43% | -4.24% |
Dividend Yield | - | - | - | - | 0.46% | 0.66% |
Payout Ratio | - | - | - | - | 108.92% | - |
Buyback Yield / Dilution | -0.18% | 0.05% | -0.60% | -0.17% | -16.43% | -13.67% |
Total Shareholder Return | -0.18% | 0.05% | -0.60% | -0.17% | -15.96% | -13.01% |